| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/12/2012 | WO2012006503A1 Anti-neuropilin antibodies and methods of use |
| 01/12/2012 | WO2012006500A2 Monoclonal antibodies against hepatitis c virus core protein |
| 01/12/2012 | WO2012006490A2 Dual variable domain immunoglobulins and uses thereof |
| 01/12/2012 | WO2012006437A2 Polypeptides having antiviral activity and methods for use thereof |
| 01/12/2012 | WO2012006341A2 Anti-ron antibodies |
| 01/12/2012 | WO2012005328A1 Antibody capable of binding to lysophosphatidylglucoside, and composition containing the antibody |
| 01/12/2012 | WO2012004773A1 New uses of nogo-a inhibitors and related methods |
| 01/12/2012 | WO2012004367A1 Agonistic antibody to cd27 |
| 01/12/2012 | WO2012003995A1 Lipid-conjugated antibodies |
| 01/12/2012 | WO2012003956A1 Cancer therapy using cldn6 target-directed antibodies in vivo |
| 01/12/2012 | WO2011145629A3 ANTIBODY CAPABLE OF BINDING TO TRANSFORMING GROWTH FACTOR ALPHA AND HAVING ANTIPROLIFERATIVE ACTIVITY ON CANCER HAVING Ras GENE MUTATION |
| 01/12/2012 | WO2011133919A4 Use of tau to monitor immunotherapy |
| 01/12/2012 | WO2011039511A4 Agents, uses and methods |
| 01/12/2012 | WO2003085121A9 Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer |
| 01/12/2012 | WO2002036070A3 Novel fish chemokine and methods for use |
| 01/12/2012 | US20120011600 Optimizing glycan processing in plants |
| 01/12/2012 | US20120010558 Photosensitizing antibody-fluorophore conjugates |
| 01/12/2012 | US20120010557 Drug Delivery System for Use in the Treatment of Vascular and Vessel-Related Pathologies |
| 01/12/2012 | US20120010390 Separation method using single polymer phase systems |
| 01/12/2012 | US20120010389 Detection of specific nitrated markers |
| 01/12/2012 | US20120010388 LeY SPECIFIC BIOTHERAPEUTIC |
| 01/12/2012 | US20120010387 Antibody variants composition |
| 01/12/2012 | US20120010270 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN TUMOR SUPPRESSING SUBTRANSFERABLE CANDIDATE 6 (TSSC6) |
| 01/12/2012 | US20120010269 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN SMS3 |
| 01/12/2012 | US20120010268 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN ACHAETE-SCUTE HOMOLOG 2 (HASH2) |
| 01/12/2012 | US20120010266 Tbc1d7 as tumor marker and therapeutic target for cancer |
| 01/12/2012 | US20120010155 Gntiii expression in plants |
| 01/12/2012 | US20120010147 Nmdar biomarkers for diagnosis and treatment of traumatic brain injury and other disorders |
| 01/12/2012 | US20120010137 Use of ixolaris, a tissue factor inhibitor, for the treatment and prevention of cancer |
| 01/12/2012 | US20120010134 Soluble non-depot insulin conjugates and uses thereof |
| 01/12/2012 | US20120009648 DNA polymerase lambda and uses thereof |
| 01/12/2012 | US20120009633 Nitrilases and methods for making and using them |
| 01/12/2012 | US20120009621 Novel antibody and antibody fragment introduced new modification sites |
| 01/12/2012 | US20120009613 Pharmaceutical composition for modulating the activity of a novel triglyceride hydrolase |
| 01/12/2012 | US20120009606 Peptide biomarkers predictive of renal function decline and kidney disease |
| 01/12/2012 | US20120009602 Reagents and Methods for Assessment of Human Tumor Malignancy and for Targeting Malignant Tumor Cells |
| 01/12/2012 | US20120009598 T2r, a novel family of taste receptors |
| 01/12/2012 | US20120009593 Analysis method for the in vitro diagnosis of benign prostatic hyperplasia (bph) in dogs by assaying canine prostate specific esterase, and bph treatment follow up |
| 01/12/2012 | US20120009579 Monocyte-derived nucleic acids and related compositions and methods |
| 01/12/2012 | US20120009216 Early detection of flaviviruses using the ns1 glycoprotein |
| 01/12/2012 | US20120009211 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 01/12/2012 | US20120009209 Enrichment and purification of infectious prion proteins |
| 01/12/2012 | US20120009205 Modified Fc Molecules |
| 01/12/2012 | US20120009201 Renal cell carcinoma biomarkers |
| 01/12/2012 | US20120009197 Anti-Human Equilibrative Nucleoside Transporter 1 (hENT1) Antibodies and Methods of Use Thereof |
| 01/12/2012 | US20120009196 Monoclonal antibodies against hepatitis c virus core protein |
| 01/12/2012 | US20120009195 Antibody neutralizers of human granulocyte macrophage colony stimulating factor |
| 01/12/2012 | US20120009194 Antibodies to endoplasmin and their use |
| 01/12/2012 | US20120009193 Method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same |
| 01/12/2012 | US20120009190 Identification and method for using the pre-ligand assembly domain of the il-17 receptor |
| 01/12/2012 | US20120009189 Antibody composition with altered fab sialylation |
| 01/12/2012 | US20120009188 Optimized fc variants |
| 01/12/2012 | US20120009186 FcGammaRIIB Specific Antibodies and Methods of Use Thereof |
| 01/12/2012 | US20120009184 Anti-C5 Alpha Antibodies |
| 01/12/2012 | US20120009182 Immunoglobulin variants with altered binding to protein a |
| 01/12/2012 | US20120009181 Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof |
| 01/12/2012 | US20120009180 Anti-abeta oligomer humanized antibody |
| 01/12/2012 | US20120009179 ANTI-Aß OLIGOMER HUMANIZED ANTIBODY |
| 01/12/2012 | US20120009178 Tweak binding antibodies |
| 01/12/2012 | US20120006716 Humanized anti-il-6 antibodies |
| 01/12/2012 | DE102008063592B4 Multifunktionaler Laborprozessbeutel für die Reinherstellung von Biomolekülen Multifunctional Laboratory Process bag for clean production of biomolecules |
| 01/12/2012 | CA2805547A1 Anti-human respiratory syncytial virus (rsv) antibodies and methods of use |
| 01/12/2012 | CA2804686A1 Dual variable domain immunoglobulins and uses thereof |
| 01/12/2012 | CA2804550A1 Agonistic antibody to cd27 |
| 01/12/2012 | CA2804399A1 Anti-ron antibodies |
| 01/12/2012 | CA2804242A1 Cancer therapy using cldn6 target-directed antibodies in vivo |
| 01/12/2012 | CA2803792A1 Anti-neuropilin antibodies and methods of use |
| 01/12/2012 | CA2803188A1 Lipid-conjugated antibodies |
| 01/11/2012 | EP2405270A1 IGFBP2-Biomarker |
| 01/11/2012 | EP2405015A2 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 01/11/2012 | EP2404998A2 Composition and method for diagnosing kidney cancer and for predicting prognosis for kidney cancer patient |
| 01/11/2012 | EP2404937A1 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
| 01/11/2012 | EP2404936A1 Cancer therapy using CLDN6 target-directed antibodies in vivo |
| 01/11/2012 | EP2404935A1 Immunoglobulin binding HOSM |
| 01/11/2012 | EP2404927A2 Isolation of five novel genes coding for new fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 01/11/2012 | EP2404616A2 Binding proteins specific for insulin-like growth factors and uses thereof |
| 01/11/2012 | EP2404615A1 Humanized antibodies to interferon alpha receptor-1 (IFNAR-1) |
| 01/11/2012 | EP2403963A1 A biomarker and treatment for cancer |
| 01/11/2012 | EP2403943A1 Vangl1 peptides and vaccines including the same |
| 01/11/2012 | EP2403880A1 Matrix metalloproteinase-7 (mmp-7) monoclonal antibodies and methods for their use in the detection of ovarian cancer |
| 01/11/2012 | EP2403879A1 Treatment of leukemias and chronic myeloproliferative diseases with antibodies to epha3 |
| 01/11/2012 | EP2403878A1 Fully human antibodies specific to cadm1 |
| 01/11/2012 | EP2403877A1 Pharmaceutical composition and method for identifying a cancerous and/or an inflammatory disease in a patient |
| 01/11/2012 | EP2403876A1 An assay for detecting vitamin d and antibodies therefor |
| 01/11/2012 | EP2403875A1 Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer |
| 01/11/2012 | EP2403874A1 Antibody formulation |
| 01/11/2012 | EP2403873A1 Novel antigen binding dimer-complexes, methods of making/avoiding and uses thereof |
| 01/11/2012 | EP2403871A1 Antibodies and epitopes specific to misfolded prion protein |
| 01/11/2012 | EP2403605A2 Secreted ap2 and methods of inhibiting same |
| 01/11/2012 | EP2403532A2 Humanized anti-cd19 antibody formulations |
| 01/11/2012 | EP2403530A2 Engineered proteins with high affinity for dota chelates |
| 01/11/2012 | EP2403529A1 Anti-rhesus d monoclonal antibody |
| 01/11/2012 | EP1737489B1 ErbB2 antagonists for tumor pain therapy |
| 01/11/2012 | EP1725666B1 Plants with reduced activity of the starch phosphorylating enzyme phosphoglucan, water dikinase |
| 01/11/2012 | EP1692181B1 Leptin antagonist and method for quantitative measurement of leptin |
| 01/11/2012 | EP1682583B1 Protein complex using immunoglobulin fragment and method for the preparation thereof |
| 01/11/2012 | EP1608399B1 Complex of sclerostin and noggin or chordin, and agents that modulate the formation of said complex |
| 01/11/2012 | EP1572121B1 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 01/11/2012 | EP1558648B1 Human monoclonal antibodies against cd20 |
| 01/11/2012 | EP1483384B1 Method for overexpression of zwitterionic polysaccharides |